Eplerenone

This classification denotes a steroid compound and antihypertensive agent with the molecular formula C24H30O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6995V82D0B, chemically known as 9,11alpha-epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester but generally known as eplerenone, which bears US NIH Compound Identifier 150310. European Medicines Agency schedules Eplerenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06574MIG. The term EPLERENONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). World Health Organization schedules eplerenone in its Anatomical Therapeutic Chemical (ATC) Classification. EPLERENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eplerenone under HS 29372900 and SITC 54153. As of Q4 2014, EPLERENONE remains the US FDA Preferred Term for this commodity. Eplerenone bears US NLM identifiers UMLS ID C0961485 and NCI Concept Code C47513. SMILES: O1C23C(C4C(CC12)(C1(OC(=O)CC1)CC4)C)C(CC1=CC(=O)CCC31C)C(=O)OC.